Literature DB >> 31568365

Screening and Management of the Hyperandrogenic Adolescent: ACOG Committee Opinion, Number 789.

.   

Abstract

Although androgen excess can manifest in many ways, the most common and recognizable symptoms are hirsutism and acne. Reports of hirsutism and acne should be taken seriously because of their possible association with medical disorders, their substantial effect on self-esteem and quality of life, and the potential for psychosocial morbidity. In patients with symptoms of androgen excess, the differential diagnosis should include physiologic hyperandrogenism of puberty, idiopathic hyperandrogenism, and polycystic ovary syndrome (PCOS). There is a great deal of overlap between the symptoms of PCOS and those of normal puberty, which makes the diagnosis of PCOS in the adolescent difficult. Treatment of acne and hirsutism should not be withheld during the ongoing longitudinal evaluation for possible PCOS. On physical examination, body mass index, blood pressure, and signs of hyperandrogenism, such as acne and hirsutism, should be evaluated. Although guidelines differ on recommended laboratory studies, most include measurement of total testosterone, free testosterone, or both, and screening for nonclassic congenital adrenal hyperplasia with a 17-hydroxyprogesterone test. Elevation of the free or total testosterone level higher than the adult female normative values is a key diagnostic feature of biochemical hyperandrogenism. Because treatment is indicated only when symptoms are distressing to the patient, the degree to which acne or hirsutism bothers the patient should be assessed. Before initiation of any medical therapy, expectations of treatment should be discussed with the patient. Anticipatory guidance is critical to help patients understand the timeline for expected responses to therapy.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31568365     DOI: 10.1097/AOG.0000000000003475

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

Review 1.  Diagnosis of Polycystic Ovary Syndrome: Which Criteria to Use and When?

Authors:  Sydney Chang; Andrea Dunaif
Journal:  Endocrinol Metab Clin North Am       Date:  2021-03       Impact factor: 4.741

2.  Care for Adolescents With Polycystic Ovary Syndrome: Development and Prescribing Patterns of a Multidisciplinary Clinic.

Authors:  C Torres-Zegarra; D Sundararajan; J Benson; H Seagle; M Witten; N Walders-Abramson; S L Simon; P Huguelet; N J Nokoff; M Cree-Green
Journal:  J Pediatr Adolesc Gynecol       Date:  2021-03-29       Impact factor: 2.046

3.  Relation between Inflammation, Oxidative Stress, and Macronutrient Intakes in Normal and Excessive Body Weight Adolescent Girls with Clinical Features of Polycystic Ovary Syndrome.

Authors:  Małgorzata Mizgier; Grażyna Jarząbek-Bielecka; Natalia Wendland; Elżbieta Jodłowska-Siewert; Marcin Nowicki; Alicja Brożek; Witold Kędzia; Dorota Formanowicz; Justyna Opydo-Szymaczek
Journal:  Nutrients       Date:  2021-03-10       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.